ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
11.24
-0.54 (-4.58%)
At close: Feb 21, 2025, 4:00 PM
11.21
-0.03 (-0.27%)
After-hours: Feb 21, 2025, 5:53 PM EST
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $1.09 billion as of February 21, 2025. Its market cap has increased by 75.06% in one year.
Market Cap
1.09B
Enterprise Value
887.65M
1-Year Change
75.06%
Ranking
Category
Stock Price
$11.24
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $1.09B, an increase of 92.23%. That is a compound annual growth rate of 33.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 1.09B | 6.54% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 800.87B |
| UnitedHealth Group | 420.77B |
| Johnson & Johnson | 389.65B |
| Novo Nordisk | 370.84B |
| AbbVie | 358.01B |
| Abbott Laboratories | 234.20B |
| AstraZeneca | 227.07B |
| Merck & Co. | 224.96B |